GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Allurion Technologies Inc (NYSE:ALUR) » Definitions » Piotroski F-Score

Allurion Technologies (Allurion Technologies) Piotroski F-Score : 3 (As of May. 13, 2024)


View and export this data going back to 2023. Start your Free Trial

What is Allurion Technologies Piotroski F-Score?

Warning Sign:

Piotroski F-Score of 3 is low, which usually implies poor business operation.

The zones of discrimination were as such:

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

Allurion Technologies has an F-score of 3. It is a bad or low score, which usually implies poor business operation.

The historical rank and industry rank for Allurion Technologies's Piotroski F-Score or its related term are showing as below:

ALUR' s Piotroski F-Score Range Over the Past 10 Years
Min: 3   Med: 3   Max: 3
Current: 3

During the past 3 years, the highest Piotroski F-Score of Allurion Technologies was 3. The lowest was 3. And the median was 3.


Allurion Technologies Piotroski F-Score Historical Data

The historical data trend for Allurion Technologies's Piotroski F-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Allurion Technologies Piotroski F-Score Chart

Allurion Technologies Annual Data
Trend Dec21 Dec22 Dec23
Piotroski F-Score
N/A N/A 3.00

Allurion Technologies Quarterly Data
Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Piotroski F-Score Get a 7-Day Free Trial Premium Member Only N/A N/A N/A N/A 3.00

Competitive Comparison of Allurion Technologies's Piotroski F-Score

For the Medical Devices subindustry, Allurion Technologies's Piotroski F-Score, along with its competitors' market caps and Piotroski F-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Allurion Technologies's Piotroski F-Score Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Allurion Technologies's Piotroski F-Score distribution charts can be found below:

* The bar in red indicates where Allurion Technologies's Piotroski F-Score falls into.


How is the Piotroski F-Score calculated?

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Dec23) TTM:Last Year (Dec22) TTM:
Net Income was -17.801 + -21.996 + -21.63 + -19.18 = $-80.61 Mil.
Cash Flow from Operations was -10.318 + -9.699 + -23.094 + -20.871 = $-63.98 Mil.
Revenue was 14.071 + 12.96 + 18.2 + 8.235 = $53.47 Mil.
Gross Profit was 11.131 + 9.968 + 13.968 + 6.43 = $41.50 Mil.
Average Total Assets from the begining of this year (Dec22)
to the end of this year (Dec23) was
(51.37 + 57.966 + 52.151 + 120.688 + 71.712) / 5 = $70.7774 Mil.
Total Assets at the begining of this year (Dec22) was $51.37 Mil.
Long-Term Debt & Capital Lease Obligation was $2.31 Mil.
Total Current Assets was $64.82 Mil.
Total Current Liabilities was $65.43 Mil.
Net Income was -6.419 + -5.405 + -13.572 + -12.348 = $-37.74 Mil.

Revenue was 12.713 + 16.25 + 16.064 + 19.184 = $64.21 Mil.
Gross Profit was 10.137 + 12.755 + 12.59 + 15.244 = $50.73 Mil.
Average Total Assets from the begining of last year (Dec21)
to the end of last year (Dec22) was
(39.351 + 0 + 0 + 0 + 51.37) / 5 = $45.3605 Mil.
Total Assets at the begining of last year (Dec21) was $39.35 Mil.
Long-Term Debt & Capital Lease Obligation was $5.27 Mil.
Total Current Assets was $43.38 Mil.
Total Current Liabilities was $75.87 Mil.

*Note: If the latest quarterly/semi-annual/annual total assets data is 0, then we will use previous quarterly/semi-annual/annual data for all the items in the balance sheet.

Profitability

Question 1. Return on Assets (ROA)

Net income before extraordinary items for the year divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

Allurion Technologies's current Net Income (TTM) was -80.61. ==> Negative ==> Score 0.

Question 2. Cash Flow Return on Assets (CFROA)

Net cash flow from operating activities (operating cash flow) divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

Allurion Technologies's current Cash Flow from Operations (TTM) was -63.98. ==> Negative ==> Score 0.

Question 3. Change in Return on Assets

Compare this year's return on assets (1) to last year's return on assets.

Score 1 if it's higher, 0 if it's lower.

ROA (This Year)=Net Income/Total Assets (Dec22)
=-80.607/51.37
=-1.56914542

ROA (Last Year)=Net Income/Total Assets (Dec21)
=-37.744/39.351
=-0.95916241

Allurion Technologies's return on assets of this year was -1.56914542. Allurion Technologies's return on assets of last year was -0.95916241. ==> Last year is higher ==> Score 0.

Question 4. Quality of Earnings (Accrual)

Compare Cash flow return on assets (2) to return on assets (1)

Score 1 if CFROA > ROA, 0 if CFROA <= ROA.

Allurion Technologies's current Net Income (TTM) was -80.61. Allurion Technologies's current Cash Flow from Operations (TTM) was -63.98. ==> -63.98 > -80.61 ==> CFROA > ROA ==> Score 1.

Funding

Question 5. Change in Gearing or Leverage

Compare this year's gearing (long-term debt divided by average total assets) to last year's gearing.

Score 0 if this year's gearing is higher, 1 otherwise.

Gearing (This Year: Dec23)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Dec22 to Dec23
=2.306/70.7774
=0.03258102

Gearing (Last Year: Dec22)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Dec21 to Dec22
=5.266/45.3605
=0.11609219

Allurion Technologies's gearing of this year was 0.03258102. Allurion Technologies's gearing of last year was 0.11609219. ==> This year is lower or equal to last year. ==> Score 1.

Question 6. Change in Working Capital (Liquidity)

Compare this year's current ratio (current assets divided by current liabilities) to last year's current ratio.

Score 1 if this year's current ratio is higher, 0 if it's lower

Current Ratio (This Year: Dec23)=Total Current Assets/Total Current Liabilities
=64.816/65.425
=0.99069163

Current Ratio (Last Year: Dec22)=Total Current Assets/Total Current Liabilities
=43.383/75.867
=0.57182965

Allurion Technologies's current ratio of this year was 0.99069163. Allurion Technologies's current ratio of last year was 0.57182965. ==> This year's current ratio is higher. ==> Score 1.

Question 7. Change in Shares in Issue

Compare the number of shares in issue this year, to the number in issue last year.

Score 0 if there is larger number of shares in issue this year, 1 otherwise.

Allurion Technologies's number of shares in issue this year was 47.651. Allurion Technologies's number of shares in issue last year was 46.502. ==> There is larger number of shares in issue this year. ==> Score 0.

Efficiency

Question 8. Change in Gross Margin

Compare this year's gross margin (Gross Profit divided by sales) to last year's.

Score 1 if this year's gross margin is higher, 0 if it's lower.

Gross Margin (This Year: TTM)=Gross Profit/Revenue
=41.497/53.466
=0.77613811

Gross Margin (Last Year: TTM)=Gross Profit/Revenue
=50.726/64.211
=0.78998925

Allurion Technologies's gross margin of this year was 0.77613811. Allurion Technologies's gross margin of last year was 0.78998925. ==> Last year's gross margin is higher ==> Score 0.

Question 9. Change in asset turnover

Compare this year's asset turnover (total sales for the year divided by total assets at the beginning of the year) to last year's asset turnover ratio.

Score 1 if this year's asset turnover ratio is higher, 0 if it's lower

Asset Turnover (This Year)=Revenue/Total Assets at the Beginning of This Year (Dec22)
=53.466/51.37
=1.04080202

Asset Turnover (Last Year)=Revenue/Total Assets at the Beginning of Last Year (Dec21)
=64.211/39.351
=1.63175015

Allurion Technologies's asset turnover of this year was 1.04080202. Allurion Technologies's asset turnover of last year was 1.63175015. ==> Last year's asset turnover is higher ==> Score 0.

Evaluation

Piotroski F-Score= Que. 1+ Que. 2+ Que. 3+Que. 4+Que. 5+Que. 6+Que. 7+Que. 8+Que. 9
=0+0+0+1+1+1+0+0+0
=3

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

Allurion Technologies has an F-score of 3. It is a bad or low score, which usually implies poor business operation.

Allurion Technologies  (NYSE:ALUR) Piotroski F-Score Explanation

The developer of the system is Joseph D. Piotroski is relatively unknown accounting professor who shuns publicity and rarely gives interviews.

He graduated from the University of Illinois with a B.S. in accounting in 1989, received an M.B.A. from Indiana University in 1994. Five years later, in 1999, after earning a Ph.D. in accounting from the University of Michigan, he became an associate professor of accounting at the University of Chicago.

In 2000, he wrote a research paper called "Value Investing: The Use of Historical Financial Statement Information to Separate Winners from Losers" (pdf).

He wanted to see if he can develop a system (using a simple nine-point scoring system) that can increase the returns of a strategy of investing in low price to book (referred to in the paper as high book to market) value companies.

What he found was something that exceeded his most optimistic expectations.

Buying only those companies that scored highest (8 or 9) on his nine-point scale, or F-Score as he called it, over the 20 year period from 1976 to 1996 led to an average out-performance over the market of 13.4%.

Even more impressive were the results of a strategy of investing in the highest F-Score companies (8 or 9) and shorting companies with the lowest F-Score (0 or 1).

Over the same period from 1976 to 1996 (20 years) this strategy led to an average yearly return of 23%, substantially outperforming the average S&P 500 index return of 15.83% over the same period.


Allurion Technologies Piotroski F-Score Related Terms

Thank you for viewing the detailed overview of Allurion Technologies's Piotroski F-Score provided by GuruFocus.com. Please click on the following links to see related term pages.


Allurion Technologies (Allurion Technologies) Business Description

Traded in Other Exchanges
N/A
Address
11 Huron Drive, Natick, MA, USA, 01760
Website
Allurion Technologies Inc is a leading medical device company that focuses on creating a best-in-class weight loss platform to treat overweight patients. Its platform, the Allurion Program, features the world's first and only swallowable, procedure-less intragastric balloon for weight loss and offers access to AI-powered remote patient monitoring tools, a proprietary behavior change program, secure messaging, and video telehealth that are delivered by the Allurion VCS. Its proprietary intragastric balloon, the Allurion Balloon, is in the form of a swallowed capsule that is administered to patients under the guidance of a healthcare provider without surgery, endoscopy, or anesthesia.
Executives
Omar Ishrak director 710 MEDTRONIC PKWY, MS LC300, MINNEAPOLIS MN 55432
Nicholas Sheridan Lewin director 3 WEST 57TH ST., 8TH FLOOR, NEW YORK NY 10019
Krishna K. Gupta director, 10 percent owner 307 HARVARD ST, CAMBRIDGE MA 02139
Christopher J Geberth officer: Chief Financial Officer 11 HURON DRIVE, SUITE 200, NATICK MA 01760
Michael R Davin director C/O CYNOSURE, INC., 5 CARLISLE ROAD, WESTFORD MA 01886
Larson Douglas Hudson director 11 HURON DRIVE, SUITE 200, NATICK MA 01760
Benoit Chardon officer: Chief Commercial Officer 11 HURON DRIVE, SUITE 200, NATICK MA 01760
Shantanu Gaur director, officer: Chief Executive Officer 11 HURON DRIVE, SUITE 200, NATICK MA 01760
Ram Chuttani officer: Chief Medical Officer 11 HURON DRIVE, SUITE 200, NATICK MA 01760